drugset / Trial / NCT02226367
Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSD
Completed
158 enrolled
Seattle Institute for Biomedical and Clinical Research
United States Department of Defense · collabVA Puget Sound Health Care System · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of the study is to evaluate if the drug prazosin: * will decrease alcohol use in active duty members of the military who served in Iraq and/or Afghanistan and * determine if presence or absence of posttraumatic stress disorder affects treatment.
Timeline
- Start
- 2015-01
- Primary completion
- 2018-09-20
- Completion
- 2018-10-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Prazosin | Unknown | 20 mg | Oral |